DeepMed Research

Royal Marsden NHS Foundation Trust

🇬🇧United Kingdom

Country: 🇬🇧United Kingdom

Ownership: Private, Subsidiary

Employees: -

Market Cap: -

Website: http://www.royalmarsden.nhs.uk

Clinical Trials

Improving Informed Consent for Early Phase Anti-Cancer Trials

Not Applicable

Conditions: Solid Neoplasms

Interventions: Other: Summary PIS and Online Video Modules

First Posted Date: 2020-05-29

Last Posted Date: 2022-03-04

Lead Sponsor: Royal Marsden NHS Foundation Trust

Target Recruit Count: 34

Registration Number: NCT04407676

Locations: 🇬🇧
Royal Marsden Hospital NHS Foundation Trust, London, United Kingdom

Investigating National Solutions for Personalised Iodine-131 Radiation Exposure

Recruiting

Conditions: Differentiated Thyroid Cancer

First Posted Date: 2020-05-18

Last Posted Date: 2023-08-18

Lead Sponsor: Royal Marsden NHS Foundation Trust

Target Recruit Count: 150

Registration Number: NCT04391244

Locations: 🇬🇧
The Royal Marsden NHS Foundation Trust, Sutton, Surrey, United Kingdom

PAveMenT: Palbociclib and Avelumab in Metastatic AR+ Triple Negative Breast Cancer

Phase 1

Recruiting

Conditions: Triple Negative Breast Cancer
Locally Advanced Breast Cancer
Recurrent Breast Cancer
Metastatic Breast Cancer
ER+ Breast Cancer
HER2-positive Breast Cancer

Interventions: Drug: Palbociclib
Drug: Avelumab

First Posted Date: 2020-04-24

Last Posted Date: 2024-12-27

Lead Sponsor: Royal Marsden NHS Foundation Trust

Target Recruit Count: 45

Registration Number: NCT04360941

Locations: 🇬🇧
University College London Hospitals NHS Foundation Trust, London, United Kingdom
🇬🇧
The Christie NHS Foundation Trust, Manchester, Greater Manchester, United Kingdom
🇬🇧
Addenbrooke's Hospital Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom

and more 5 locations

Feasibility of Frailty Assessment and Implementation of Interventions in Women Over 70 With Epithelial Ovarian Cancer

Not Applicable

Conditions: Quality of Life
Chemotherapy
Ovarian Cancer
Aged
Tolerance

Interventions: Other: Functional Geriatric Assessment

First Posted Date: 2020-03-09

Last Posted Date: 2020-03-09

Lead Sponsor: Royal Marsden NHS Foundation Trust

Target Recruit Count: 120

Registration Number: NCT04300699

Multi-Centre Observational Study of Maintenance Niraparib in Treatment of Ovarian CanceR

Conditions: Ovarian Cancer
Peritoneal Cancer
Fallopian Tube Cancer

Interventions: Other: Niraparib

First Posted Date: 2020-03-04

Last Posted Date: 2022-01-21

Lead Sponsor: Royal Marsden NHS Foundation Trust

Target Recruit Count: 350

Registration Number: NCT04295577

Locations: 🇬🇧
Velindre Cancer Centre, Velindre University NHS Trust, Cardiff, United Kingdom
🇬🇧
Belfast Health & Social Care Trust, Belfast, United Kingdom
🇬🇧
St James's University Hospital, Leeds, United Kingdom

and more 12 locations

A Phase Ib Combination Study of Rituximab, TinostamustinEAnd CHeckpoint Inhibition With Pembrolizumab in Relapsed/Refractory DLBCL

Phase 1

Withdrawn

Conditions: Relapsed or Refractory Diffuse Large B-cell Lymphoma

Interventions: Drug: Tinostamustinein
Drug: Pembrolizumab
Drug: Rituximab

First Posted Date: 2020-02-21

Last Posted Date: 2020-02-21

Lead Sponsor: Royal Marsden NHS Foundation Trust

Registration Number: NCT04279938

Locations: 🇬🇧
The Royal Marsden NHS Foundation Trust, Sutton, Surrey, United Kingdom

Men's Experience of Prostate Biopsy

Completed

Conditions: Prostate Biopsy

First Posted Date: 2020-02-18

Last Posted Date: 2025-05-01

Lead Sponsor: Royal Marsden NHS Foundation Trust

Target Recruit Count: 18

Registration Number: NCT04274725

Locations: 🇬🇧
Epsom General Hospital, London, United Kingdom
🇬🇧
Royal Marsden NHS Foundation Trust, London, United Kingdom

Lung Nodule Imaging Biobank for Radiomics and AI Research

Conditions: Lung Cancer
Pulmonary Nodule, Solitary
Lung Neoplasms
Pulmonary Nodule, Multiple

Interventions: Diagnostic Test: Machine Learning Classification

First Posted Date: 2020-02-17

Last Posted Date: 2021-06-11

Lead Sponsor: Royal Marsden NHS Foundation Trust

Target Recruit Count: 1000

Registration Number: NCT04270799

Locations: 🇬🇧
University College London Hospitals NHS Foundation Trust, London, United Kingdom
🇬🇧
The Royal Brompton NHS Foundation Trust, London, United Kingdom
🇬🇧
Royal Marsden - Surrey, Sutton, England, United Kingdom

and more 2 locations

Optimising Radiation Therapy in Head and Neck Cancers Using Functional Image-Guided Radiotherapy and Novel Biomarkers

Phase 1

Conditions: Head and Neck Cancer

Interventions: Radiation: Adaptive Radiotherapy

First Posted Date: 2020-01-27

Last Posted Date: 2021-07-22

Lead Sponsor: Royal Marsden NHS Foundation Trust

Target Recruit Count: 73

Registration Number: NCT04242459

Locations: 🇬🇧
Head and Neck Unit, Royal Marsden Hospital, Sutton, Surrey, United Kingdom

Pembrolizumab and Hypofractionated Stereotactic Radiotherapy in Patients With Malignant Pleural Mesothelioma

Phase 1

Terminated

Conditions: Advanced Malignant Pleural Mesothelioma

Interventions: Drug: Pembrolizumab
Radiation: Stereotactic Body Radiotherapy (SBRT)

First Posted Date: 2019-11-18

Last Posted Date: 2023-08-07

Lead Sponsor: Royal Marsden NHS Foundation Trust

Target Recruit Count: 3

Registration Number: NCT04166734

Locations: 🇬🇧
Royal Marsden NHS Foundation Trust, Chelsea, United Kingdom
🇬🇧
Beatson West of Scotland Cancer Centre, Glasgow, United Kingdom

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy